tradmap

PRLB Financials Proto Labs Inc

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 4.2% per year over the past 5 years.
  • Net income has grown slower than revenue (-16.0% vs 4.2% per year).
  • Operating margin has contracted, at 4.7% in the latest year.
  • Free cash flow has declined 0.1% per year over the past 5 years.
Revenue & net income
-$103M $215M $533M $0 2012 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-21% 18% 56% 0% 2012 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-15% 1% 17% 0% 2012 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $34M $69M 2012 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $64M $128M 2012 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$124M -$523000 $123M $0 2012 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $533M $21M 44.5% 4.7% 3.2% 2.8% $60M $111M
2024 $501M $17M 44.6% 4.0% 2.5% 2.2% $69M $89M
2023 $504M $17M 44.1% 5.6% 2.5% 2.2% $45M $84M
2022 $488M -$103M 44.1% -20.1% -14.8% -12.9% $40M $57M
2021 $488M $33M 45.6% 8.3% 4.0% 3.6% $21M $66M
2020 $434M $51M 50.1% 13.8% 7.9% 6.8% $60M $128M
2019 $459M $64M 51.3% 17.4% 10.9% 9.4% $54M $125M
2018 $446M $77M 53.6% 20.0% 14.1% 12.4% $36M $85M
2017 $344M $52M 56.3% 21.0% 11.2% 10.0% $49M $37M
2016 $298M $43M 56.0% 20.7% 11.2% 10.3% $44M $0 $69M
2015 $47M 14.2% 12.9% $20M $0 $48M
2014 $42M 15.7% 14.5% $43M
2013 $35M 16.7% 15.3% $363000 $43M
2013 $28M 16.1% 14.6% $28M
2012 $24M 15.3% 13.9% $8M $37M

Valuation over time

How the market has priced PRLB against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 45.9 91.9 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.8 3.7 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is PRLB growing its revenue and profit?

Over the past 5 years, Proto Labs Inc's revenue has grown 4.2% per year, and net income declined 16.0% per year. These are computed facts, not advice.

How much debt does PRLB have?

As of FY2025, Proto Labs Inc reported — of total debt against $111M of cash.

What is PRLB's profit margin?

In FY2025, gross margin was 44.5%, operating margin 4.7%, and net margin 4.0%.

What is PRLB's P/E ratio?

As of Sep '26, Proto Labs Inc traded at a price-to-earnings ratio of about 89.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.